| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K02251932 |
| PharmacoGx | BRD-K02251932 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DCAF10 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | PSMA6 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | HHEX | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | NAT6 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | TUSC2 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | CTB-133G6.1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | RNASEK-C17orf49 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | SPECC1L | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | DNM2 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | CD300LF | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
